NFA
BIOL

Nationwide Fund Advisors’s Biolase, Inc. BIOL Stock Holding History

Nationwide Fund Advisors’s Portfolio BIOL Stock Details BIOL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-2
Closed -$74K – 3215
2013
Q4 		$74K Hold
2
– – ﹤0.01% 3019
2013
Q3 		$49K Buy
2
+1
+100% +$32.2K ﹤0.01% 3052
2013
Q2 		$36K Buy
+1
New +$55.9K ﹤0.01% 3018

Other funds holding BIOL

OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
PCMI
Princeton Capital Management Inc Princeton, New Jersey $198M AUM 28.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
TA
Teton Advisors Rye, New York $142M AUM 42.07% 1-Year Est. Return

Nationwide Fund Advisors's BIOL Position: Q1 2014 in Review

Nationwide Fund Advisors sold out of Biolase, Inc. (BIOL) in Q1 2014, closing a stake of 2 shares — an estimated $74K sold.

Nationwide Fund Advisors first reported a position in BIOL in Q2 2013 and held it in 3 quarters. The position peaked at $74K in Q4 2013. 44 funds tracked by Wall St. Rank hold BIOL as of Q1 2014.

  • Nationwide Fund Advisors reported no remaining Biolase, Inc. position as of Q1 2014 after selling out during the quarter.
  • Nationwide Fund Advisors sold 2 Biolase, Inc. shares in Q1 2014, an estimated $74K.
  • Nationwide Fund Advisors first reported a position in Biolase, Inc. in Q2 2013 and held it in 3 quarters.
  • Nationwide Fund Advisors's Biolase, Inc. position peaked at $74K in Q4 2013.
  • 44 funds tracked by Wall St. Rank held Biolase, Inc. as of Q1 2014.

Based on Nationwide Fund Advisors's 13F filing for Q1 2014, filed 9 May 2014.